Viewing nowEson Tablet (Eperisone Hydrochloride)
Eperisone Hydrochloride 50mg
Prescription medication
Korea Union Pharm Co., Ltd.

MFDS item code 200411033 · Notified 2004.09.22 · Insurance code 665501990
Treatment of musculoskeletal diseases (painful muscle spasms) and neurological disorders (spastic paralysis)
This medication is effective for muscle pain and cramps caused by musculoskeletal diseases, such as pain around the shoulders and neck, shoulder periarthritis, and low back pain. It is also used to treat spastic paralysis due to neurological disorders and helps alleviate muscle stiffness caused by various neurological issues, including cerebrovascular accidents and complications from spinal and brain injuries, as well as cerebral palsy. This medication significantly contributes to improving the daily life of patients by reducing muscle tension and pain. Therefore, it is used for the relief of symptoms associated with these musculoskeletal and neurological disorders.
For Eperisone Hydrochloride, take 50 mg orally three times a day after meals. Adjust dosage as appropriate based on age and symptoms.
This medication should not be used by certain patients. First, patients who are allergic to this medication or suffer from severe myasthenia gravis should not take it. Additionally, this medication contains lactose, and patients with a genetic disorder that affects lactose digestion should also avoid taking it. There are patients who need to be cautious when using this medication. Patients with a history of hypersensitivity to drugs or those with impaired liver function should use this medication cautiously, as it may worsen liver function. During the use of this medication, various side effects may occur, so careful monitoring is necessary. Rarely, shock reactions may occur, so if symptoms appear, administration should be stopped immediately, and appropriate treatment should be sought. Liver enzymes may also increase, so regular liver function tests are recommended. Symptoms related to kidney or blood abnormalities, such as anemia, may occur and should be carefully monitored. Skin rashes or itching may occur, and neurologic symptoms may include insomnia, drowsiness, headache, and limb paralysis. Gastrointestinal symptoms may include nausea, vomiting, loss of appetite, and abdominal pain. Urinary symptoms may present as difficulty urinating, and systemic symptoms may include weakness and dizziness. Severe adverse reactions, such as toxic epidermal necrolysis syndrome, have been reported rarely. If symptoms such as fever, skin rash, blisters, itching, eye redness, or stomatitis appear, administration should be stopped immediately, and medical attention should be sought. During the course of this medication, symptoms such as weakness, drowsiness, and staggering may occur, so the dosage should be reduced or administration should be stopped in these instances. Additionally, driving or operating hazardous machinery should be avoided due to drowsiness or decreased concentration. Caution is needed for potential interactions when co-administering with other medications, especially similar drugs or certain muscle relaxants. Pregnant or potentially pregnant women should use this medication only if the benefits outweigh the risks since its safety is not confirmed. Nursing mothers should avoid this medication, and if unavoidable, breastfeeding should be discontinued. The safety of this medication has not been well established for children, so caution is warranted, and elderly patients may require dosage adjustments due to decreased physical function. Finally, this medication should be stored in a safe place out of the reach of children, and transferring to other containers should be avoided as it may cause accidents or affect the quality of the medication.
Shock (anaphylactic reaction), angioedema, toxic epidermal necrolysis syndrome and mucocutaneous-ocular syndrome (Stevens-Johnson syndrome), liver dysfunction (increased ALT, AST, ALP), kidney abnormalities (proteinuria, increased BUN), anemia, severe skin adverse reactions such as fever with severe rash, blisters, skin peeling, and pain in oral/ocular mucosa.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air ingress and is best kept at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness for a longer period.
White, round tablet
30 tablets/bottle, 1000 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEperisone Hydrochloride 50mg
Prescription medication
Korea Union Pharm Co., Ltd.

Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Prescription medication
Aju Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Eperisone Hydrochloride 50mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.